COSCIENS Biopharma Inc. (CSCI) — Cash Flow-to-Debt Ratio
COSCIENS Biopharma Inc. (CSCI) has a Cash Flow-to-Debt Ratio of -0.22x as of June 2025, meaning its operating cash flow of $-4.45 Million could theoretically repay 0% of its total liabilities ($20.46 Million) in one year. Check CSCI cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
COSCIENS Biopharma Inc. Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for COSCIENS Biopharma Inc. across 29 annual periods. Also explore COSCIENS Biopharma Inc. total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for COSCIENS Biopharma Inc. (1996–2024)
Year-by-year debt coverage analysis for COSCIENS Biopharma Inc.. For market capitalisation and broader financial context, see market value of COSCIENS Biopharma Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.66x | $-14.57 Million | $21.91 Million | ▲ +30.2% |
| 2023 | -0.95x | $-2.58 Million | $2.71 Million | ▼ -173.1% |
| 2022 | 1.30x | $5.23 Million | $4.01 Million | ▲ +23.7% |
| 2021 | 1.05x | $2.75 Million | $2.61 Million | ▲ +16.3% |
| 2020 | 0.91x | $3.49 Million | $3.85 Million | ▲ +409.3% |
| 2019 | 0.18x | $675.29K | $3.79 Million | ▲ +117.7% |
| 2018 | -1.01x | $-1.56 Million | $1.55 Million | ▼ -436.6% |
| 2017 | 0.30x | $1.25 Million | $4.19 Million | ▼ -75.6% |
| 2016 | 1.22x | $3.63 Million | $2.97 Million | ▲ +140.5% |
| 2015 | 0.51x | $2.87 Million | $5.64 Million | ▲ +33.3% |
| 2014 | 0.38x | $1.84 Million | $4.82 Million | ▲ +278.1% |
| 2013 | 0.10x | $460.21K | $4.56 Million | ▲ +433.6% |
| 2012 | -0.03x | $-117.82K | $3.89 Million | ▼ -113.7% |
| 2011 | 0.22x | $791.62K | $3.58 Million | ▲ +60.3% |
| 2010 | 0.14x | $479.50K | $3.47 Million | ▲ +159.0% |
| 2009 | -0.23x | $-925.47K | $3.96 Million | ▼ -10.3% |
| 2008 | -0.21x | $-909.41K | $4.29 Million | ▲ +40.8% |
| 2007 | -0.36x | $-1.10 Million | $3.06 Million | ▼ -484.3% |
| 2006 | 0.09x | $140.59K | $1.51 Million | ▲ +142.6% |
| 2005 | -0.22x | $-368.84K | $1.69 Million | ▼ -280.8% |
| 2004 | -0.06x | $-76.65K | $1.33 Million | ▼ -171.1% |
| 2003 | 0.08x | $54.42K | $673.27K | ▲ +215.4% |
| 2002 | -0.07x | $-57.75K | $824.69K | ▲ +85.5% |
| 2001 | -0.48x | $-457.45K | $948.90K | ▼ -70.5% |
| 2000 | -0.28x | $-506.44K | $1.79 Million | ▼ -106.6% |
| 1999 | -0.14x | $-207.14K | $1.51 Million | ▲ +91.2% |
| 1998 | -1.56x | $-1.62 Million | $1.04 Million | ▼ -28.5% |
| 1997 | -1.22x | $-3.14 Million | $2.59 Million | ▼ -578.5% |
| 1996 | -0.18x | $-1.39 Million | $7.73 Million | — |